Publications in Series

Publications Series

NIAAA Alcohol Alert Series

Back to Top

CSAP Substance Abuse Resource Guides

These Resource Guides typically contain sections on Prevention Materials; Studies, Articles, and Reports; and Groups, Organizations, and Programs. Each guide focuses on one special population or topic as it relates to substance abuse.

Back to Top

CSAP Prevention Monographs

Communicating About Alcohol and Other Drugs: Strategies for Reaching Populations at Risk. CSAP Prevention Monograph 5
(1992) 402 pp. BK170
This monograph represents a three-pronged initiative to 1) identify the knowledge, attitudes, and practices of youth (and their families) at special risk for developing substance abuse problems; 2) identify gaps in messages and materials; and 3) recommend strategies to reach these populations. The focus is on reaching children of alcoholics, African-American youth, Hispanic youth, parents, and health care providers.

Preventing Adolescent Drug Use: From Theory to Practice. CSAP Prevention Monograph 8
(1991) 270 pp. BK185
Preventing Adolescent Drug Use explores the complex world of adolescents and their families and the transitions that influence their development and behavior, and the factors that place them at risk for substance abuse and addiction. The monograph also contains practical information about methods of identifying, reaching, retaining, and serving youth, and the importance of early intervention.

Crack Cocaine: A Challenge for Prevention. CSAP Prevention Monograph 9
(1991) 71 pp. BK190
The history and epidemiology of crack cocaine is presented in this report, which also demonstrates aspects of the drug and its use that pose unique concerns to the field of prevention. Monograph 9 examines problems specific to crack cocaine that require specially focused prevention strategies and recommendations for a crack cocaine research agenda.

A Promising Future: Alcohol and Other Drug Problem Prevention Services Improvement. CSAP Prevention Monograph 10
(1992) 127 pp. BK191
This volume includes discussions of the economic and human costs of substance abuse-related problems and how these costs have led to increased Federal Government support for substance abuse prevention. It also addresses the prevention of HIV infection and the clinical epidemiology of drug abuse and AIDS.

Identifying the Needs of Drug Affected Children: Public Policy Issues. CSAP Prevention Monograph 11
(1992) 169 pp. BK195
Monograph 11 is based on papers and discussions from CSAP's first Issues Forum held in November 1990, which brought experts together to define the needs of substance abuse exposed children ages 2 to 5. The monograph describes the problem, our current solutions, and suggestions of what needs to be done about this growing problem.

The Second National Conference on Preventing and Treating Alcohol and Other Drug Abuse, HIV Infection, and AIDS in Black Communities: From Advocacy to Action. CSAP Prevention Monograph 13
(1992) 500 pp. BKD078
This monograph of conference presentations describes initiatives against substance abuse, HIV infection, and AIDS in African-American communities. Experts discuss resources to convert prevention and treatment knowledge into practical efforts to eradicate these problems from communities nationwide.

Experiences with Community Action Projects: New Research in the Prevention of Alcohol and Other Drug Problems. CSAP Prevention Monograph 14
(1993) 301 pp. BKD087
Based on the second international research symposium, this monograph is the sequel to CSAP Prevention Monograph 4 and the first symposium. Following the format of the conference, papers are organized under broad headings: conceptual issues in evaluating community action; experiences with policy adoption case studies; community trials design issues; and needs assessments or natural experiments in special settings.

Back to Top

CSAP Technical Report Series

Breaking New Ground for Youth at Risk: Program Summaries. CSAP Technical Report 1
(1992) 137 pp. BK163
Breaking New Ground summarizes the 130 demonstration grants funded by CSAP in 1987, to develop, test, and evaluate approaches for working with youth in high-risk environments. Prevention, intervention, and treatment programs, as well as comprehensive, community-wide projects, are examined.

Urine Specimen Collection Handbook for Federal Workplace Drug Testing Programs. CSAP Technical Report 12
(1996, CSAP) 54 pp. PHD730
The collector of urine specimens is key to the success of a drug-testing program and is the one individual with whom all donors will have direct, face-to-face contact. This handbook provides guidance to collectors in accordance with the Mandatory Guidelines for Federal Workplace Drug Testing Programs.

A Review of Alternative Activities and Alternative Programs in Youth Oriented Prevention. CSAP Technical Report 13
(1996) 44 pp. PHD731
Youth who participate in alternative activities tend to be less likely to use alcohol, tobacco, and drugs. Alternative programming involves activities, programs, and events that are free of alcohol, tobacco, and drugs. Designed for policymakers and service providers, this report explores alternative programming as a means of preventing substance abuse.

Medical Review Officer Manual for Federal Workplace Drug Testing Programs. CSAP Technical Report 15
(1997, CSAP) 72 pp. PHD748
This manual covers the medical review officer's (MRO's) involvement in the review and interpretation of drug testing results. Guidelines, the review process, specific drug class issues, specimen issues, and documentation and recordkeeping are discussed.

Back to Top

CSAP Communications Technical Assistance Bulletins

This series of short informational bulletins will assist program planners in developing substance abuse prevention materials. Currently, the series includes 11 titles that can be ordered (MS490) in a shrink-wrapped kit. The kit also contains an insertable notebook cover and spine. In addition, bulletins can be ordered individually; see corresponding order numbers below. All bulletins are black text on white paper—-perfect for photocopying, and three-hole punched for easy assembly into a three-ring binder.

Items in the shrink-wrapped kit include:

A Discussion Guide Can Enhance Your Presentation
(Reprint 1994) 4 pp. MS496
Discussion guides help clarify and reinforce the message that is presented and can be used with videotapes, films, puppet shows, plays, or skits. This bulletin explains the typical contents of a discussion guide as well as tips for handling the discussion.

A Key Step in Developing Prevention Materials Is To Obtain Expert and Gatekeeper Reviews
(Reprint 1994) 8 pp. MS492
This bulletin provides a step-by-step process for obtaining advice from expert reviewers or gatekeepers. It lays the groundwork for a successful review procedure and includes recommendations for identifying qualified experts and getting their help.

Careful Concept Development Paves the Way to Effective Prevention Materials
(1994) 8 pp. MS493
Using a concept development process based on established health communication principles can help create products that convey the right message to the right people. This bulletin outlines a process for generating ideas, identifying options, considering different approaches, and making conscious choices before making final decisions about the development of prevention materials.

Conducting Focus Groups with Young Children Requires Special Considerations and Techniques
(Reprint 1994) 12 pp. MS501
This bulletin discusses ways to modify standard techniques to accommodate the special needs of and concerns for children ages 5-12.

Following Specific Guidelines Will Help You Assess Cultural Competence in Program Design, Application, and Management
(1994) 4 pp. MS500
The bulletin presents seven indicators or guidelines that program developers, evaluators, and managers can use to gauge whether a program is operating from a culturally competent base. The bulletin explains why culture should be a consideration in assessing prevention programs and describes the cultural elements that are essential to an overall evaluation.

Pretesting Is Essential; You Can Choose from Various Methods
(Reprint 1994) 8 pp. MS498
Pretesting can be used to design effective substance abuse prevention messages and materials. This bulletin presents six methods from which to choose and discusses factors to consider in selecting the appropriate pretesting methods.

You Can Avoid Common Errors As You Develop Prevention Materials
(Reprint 1994) 8 pp. MS497
This bulletin focuses on the public health principles and guidelines with which prevention programmers most often fail to comply in the development of messages and materials. This bulletin also provides examples to illustrate clear, positive communication, as well as the mixed communication that should be avoided.

You Can Increase Your Media Coverage
(1994) 8 pp. MS491
You Can Increase Your Media Coverage explains how reviewing the basic tools of media relations can ensure good media coverage. The bulletin discusses the importance of creating a media list, using proactive approaches, selecting spokespersons, and developing relationships with reporters, editors, publishers, and producers.

You Can Manage Focus Groups Effectively for Maximum Impact
(Reprint 1994) 8 pp. MS495
This bulletin provides an overview of what focus group managers need to consider when using focus groups to gauge audience opinions, knowledge, and feelings toward prevention messages and materials.

You Can Prepare Easy-To-Read Materials
(Reprint 1994) 8 pp. MS499
Everyone benefits from materials that are clear and concise. This bulletin presents a five-step approach, including the SMOG readability formula, to ensure that the target audience understands the substance abuse prevention message as the developer intended.

You Can Use Communication Principles To Create Culturally Sensitive and Effective Prevention Materials
(Reprint 1994) 12 pp. MS494
This bulletin explores the role that culture plays in shaping an individual's attitudes and values. The bulletin also suggests techniques for targeting audiences and provides specific steps for developing culturally appropriate messages and materials using the health communications process.

Other Bulletins not available in the shrink-wrapped kit include:

Communicating Appropriately With Asian and Pacific Islander Audiences
(1997) 12 pp. MS701
It is important to recognize and respect the geographic, ethnic, cultural, social, and linguistic diversity of Asian and Pacific Islander audiences. This bulletin discusses the challenges of creating prevention messages and products in the context of varying cultures and other factors. The bulletin also talks about substance abuse patterns and the impact of immigration.

Developing Effective Messages and Materials for Hispanic/Latino Audiences
(1997) 12 pp. MS703
Hispanics/Latinos make up a multicultural community that is the product of an ongoing process of simultaneous migration from many difference countries, including Mexico, Cuba, and Puerto Rico, among others. This bulletin explains the challenges of reaching specific groups within this diverse community. The bulletin also explains how to define the target audience, create relevant messages, and get materials into the community.

Evaluating the Results of Communication Programs
(1998) 16 pp. MS706
This bulletin describes how to plan and conduct outcome evaluation. It also explains the benefits of conducting outcome evaluation to document the results of communication efforts.

Identifying the Target Audience
(1997) 6 pp. MS700
Identifying the Target Audience is designed to help users figure out who they need to reach and why, and if and when to divide the larger audience into segments. The bulletin also shows how to find out more about an audience, so that appropriate prevention messages can be created.

Urban Youth Public Education for the African American Community
(1997) 6 pp. MS702
This bulletin talks about the importance of involving everyone in the community—youth, adult role models, churches, businesses, the media—in substance abuse prevention efforts. Also suggests ways to conduct a similar campaign in the local community.

Working with Mass Media
(1998) 24 pp. MS708
Ensuring good media coverage and effectively handling communications in a crisis is vital. This bulletin presents media planning information to ensure good media coverage in urban and rural settings.

Back to Top

CSAP Drug-Free Communities Series

Prevention Plus III: Assessing Alcohol and Other Drug Prevention Programs at the School and Community Level
(1991) 470 pp. BK188
Provides up-to-date tools and techniques for substance abuse prevention, planning, and implementation. Helps to demystify the program evaluation process and encourages participation by all members of the community. For school and community leaders, individuals, and communities that want to get involved.

Back to Top

NIDA Infofax

The National Institute on Drug Abuse (NIDA) reports the latest research findings on treatment and prevention research, epidemiology, and behavioral pharmacology in NIDA Infofax. All are concise (2-4 pages) fact sheets that will keep prevention and treatment practitioners, clinicians, researchers, administrators, and policy makers up-to-date on advances in the field. These items are available separately, or in sets as follows:

NIDA Infofax Set: General Drug Information NIF01
Spanish version--Información general sobre drogas, NIF01S
Health Effects of Specific Drugs: Other Drugs:

NIDA Infofax Set: Treatment and Prevention NIF02
Spanish version--Tratamiento y prevención, NIF02S

NIDA Infofax Set: Statistics and News Releases NIF03
Spanish version--Estadítucas y comunicado de noticias, NIF03S

Survey Data:

News Releases:
NIDA

Back to Top

NIDA Research Monograph Series

Adolescent Drug Abuse: Analyses of Treatment Research. NIDA Research Monograph 77
(Reprint 1994) M077
This monograph presents an overview of adolescent drug abuse treatment research and points out the many difficulties associated with adolescent clinical studies. The monograph also reviews research on the various steps in the treatment process assessment, treatment selection, treatment delivery, and aftercare.

Compulsory Treatment of Drug Abuse: Research and Clinical Practice. NIDA Research Monograph 86
(Reprint 1994) M086
Volume 86 of the NIDA Research Monograph series explores the efficacy of compulsory treatment for drug abusers. This report includes studies of the influence of coercion on a variety of treatment outcomes, as well as the costs and potential benefits of compulsory treatment.

AIDS and Intravenous Drug Abuse: Future Directions for Community-Based Prevention Research. NIDA Research Monograph 93
(Reprint 1994) M093
Successful models in prevention/outreach for AIDS education for drug abusers and training for drug treatment personnel are presented in this monograph. It also describes strengths and weaknesses of the programs and the salient issues to consider when establishing such a program.

Problems of Drug Dependence, 1989. NIDA Research Monograph 95
(1990) 727 pp. M095
The Problems of Drug Dependence, 1989 monograph contains papers presented at the 51st Annual Scientific Meeting of the Committee on Problems of Drug Dependence. Topics covered include use of animals in research, the 1988 Anti-Drug Abuse Act, current alcoholism research, illicit drug contamination, NIDA's Medication Development Program, drug testing, opioid receptors, and physical actions of cocaine and cocaine treatment issues.

The Collection and Interpretation of Data from Hidden Populations. NIDA Research Monograph 98
(1990) 162 pp. M098
This monograph addresses qualitative approaches to the study of drug abuse. Volume 98 focuses on techniques designed to access "hidden populations," such as the homeless and transient, the mentally ill, school dropouts, and other "street people."

Cardiovascular Toxicity of Cocaine: Underlying Mechanisms. NIDA Research Monograph 108
(1991) 238 pp. M108
Based on an August 9-10, 1989 technical review meeting entitled Cardiovascular Toxicity of Cocaine: Underlying Mechanisms, this monograph consists of a collection of research papers presented at the meeting. Chapters discuss the maternal-fetal cardiovascular system, cocaine-induced myocardial depression, and the effects of cocaine on the physiology of exercise.

Molecular Approaches to Drug Abuse Research, Volume I. NIDA Research Monograph 111
(1991) 223 pp. M111
This monograph is based on the proceedings of a NIDA technical review that assessed current drug abuse research on the molecular level, including receptor cloning, neurotransmitter expression, and molecular genetics. This research promises to yield new understanding of the underlying basis of addiction and consequences of long-term abuse.

Emerging Technologies and New Directions in Drug Abuse Research. NIDA Research Monograph 112
(1991) 335 pp. M112
Emerging Technologies presents the proceedings of a NIDA technical review that discussed the impact of new technological advances on drug abuse research. The papers focus on innovative methodologies—from biological cloning techniques to computer-aided imaging—that could alter the current and future directions and applications of research related to drugs of abuse.

Methodological Issues in Controlled Studies on Effects of Prenatal Exposure to Drug Abuse. NIDA Research Monograph 114
(1991) 372 pp. M114
Prenatal exposure to drugs of abuse has adversely affected the lives of hundreds of thousands of babies born each year in the United States to drug-dependent mothers. This report presents the proceedings of the first NIDA technical review related to the conduct of controlled studies on the effect of prenatal exposure to drugs of abuse.

Drug Discrimination: Application to Drug Abuse Research. NIDA Research Monograph 116
(1992) 408 pp. M116
This monograph is the first to address drug discrimination. The report deals primarily with the techniques and findings of experiments that analyze how organisms discriminate drugs from other substances and placebos.

Methodological Issues in Epidemiological, Prevention, and Treatment Research on Drug Exposed Women and Their Children. NIDA Research Monograph 117
(1992) 399 pp. M117
Methodological Issues discusses the effects of prenatal exposure to drugs; physical and behavioral aspects of the mother, child, and their relation to each other; intervention issues; and legal issues affecting women whose drug use has affected their children.

Molecular Approaches to Drug Abuse Research, Volume II. NIDA Research Monograph 126
(1992) 164 pp. M126
This monograph summarizes recent progress in drug abuse research achieved through molecular approaches; reviews relevant technological advances in the field of molecular biology and genetics; and introduces promising new research areas.

Progress and Issues in Case Management. NIDA Research Monograph 127
(1992) 412 pp. M127
Volume 127 of this series discusses research studies on case management in the areas of street outreach, treatment, waiting list reduction, and criminal justice. The monograph suggests various models of case management and discusses the benefits of case management.

Impact of Prescription Drug Diversion Control Systems on Medical Practice and Patient Care. NIDA Research Monograph 131
(1993) 343 pp. M131
This report discusses the impact of prescription drug abuse on public health and the systems in place to minimize abuse and its impact on patient care. It also explores the gaps in our ability to evaluate existing diversion control systems.

Medications Development: Drug Discovery, Databases, and Computer-Aided Drug Designs. NIDA Research Monograph 134 (1993) 274 pp. M134
Medications Development discusses the drug discovery process and new techniques and technologies used to develop medications for drug abuse treatment.

Assessing Neurotoxicity of Drugs of Abuse. NIDA Research Monograph 136
(1993) 281 pp. M136
Various methodologies are used to research the neurotoxicity of drugs of abuse. This monograph explores the methods used to determine the neurotoxicity of several abused substances, including amphetamine and its congeners, tetrahydro-cannabinol, and phencyclidine.

Imaging Techniques in Medications Development: Preclinical and Clinical Aspects. NIDA Research Monograph 138
(1994) M138
This report discusses imaging techniques such as PET, SPECT, and MRI with special emphasis on imaging of neural receptors.

Discovery of Novel Opioid Medications. NIDA Research Monograph 147
(1995) M147
This report reviews the pharmacology, neuropharmacology, and molecular biology of potential pharmacotherapies for opioids, novel opioids, and non-opioids.

Epidemiology of Inhalant Abuse: An International Perspective. NIDA Research Monograph 148
(1995) M148
Volume 148 in this series describes the epidemiology of inhalant use in the United States and in selected countries around the world. The monograph discusses unique problems associated with investigations of inhalant use. It also suggests methodologies that might be utilized to investigate the high risk, difficult-to-reach groups who use inhalants in various countries.

Integrating Behavioral Therapies with Medications in the Treatment of Drug Abuse. NIDA Research Monograph 150
(1995) M150
Latest research findings, including state-of-the-art techniques and procedures regarding the integration of psychosocial and pharmacological treatments, are examined in this report.

Membranes and Barriers: Targeted Drug Delivery. NIDA Research Monograph 154
(1995) M154
Membranes and Barriers discusses the ability of drugs to effectively cross the various membrane barriers and reach the receptors which allow the drugs to produce biological effect(s). The monograph discusses the modern drug design techniques that make it now possible to design drugs that are selectively delivered to a specific target. Mechanisms of drug transport are also discussed in terms of prodrugs, stable drugs, peptidomimetics, etc.

Reviewing the Behavioral Science Knowledge Base on Technology Transfer. NIDA Research Monograph 155
(1995) M155
This report discusses comprehensive approaches to technology transfer coming from several disciplines, including behavioral science. The monograph also covers the development of technology transfer strategies, setting them in the larger context of partnership efforts with community constituencies and overall changes in health care and information technology.

Adolescent Drug Abuse: Clinical Assessment and Therapeutic Interventions. NIDA Research Monograph 156
(1995) M156
Adolescent Drug Abuse presents an overview of clinical assessment procedures, service delivery strategies, and therapeutic interventions designed specifically for youth. Special attention is given to drug-related medical problems, cultural issues, and family involvement.

Qualitative Methods in Drug Abuse and HIV Research. NIDA Research Monograph 157
(1995) M157
Volume 157 of this series reviews current applications of qualitative methods in drug abuse and HIV/AIDS prevention research. Emphasis is on the use of innovative ethnographic methods of accessing hidden populations, target sampling, identifying drug use and HIV/AIDS risk behaviors, developing culturally appropriate risk reduction messages, implementing interventions, and evaluating program results.

Biological Mechanisms and Perinatal Exposure to Drugs. NIDA Research Monograph 158
This item is currently out of stock.
(1995) M158
This monograph reviews the current research findings in the area of perinatal exposure to abused drugs and its impact on various biological systems during the developmental period.

Individual Differences in Biobehavioral Etiology of Drug Abuse. NIDA Research Monograph 159
(1996) 358 pp. M159
The purpose of this monograph is to provide a platform of ideas from which new direction for research in the biobehavioral etiology of substance abuse can be developed. Three research areas are discussed: genetic bases, neurophysiological correlates, and neurochemical factors underlying drug abuse risk or resistance.

Molecular Approaches to Drug Abuse Research, Volume III. NIDA Research Monograph 161
(1996) 232 pp. M161
This monograph provides the highlights from the third conference on molecular approaches to drug abuse research, held in March 1994 at NIH. Cutting-edge research is presented on transgenic/knockout animal models and other genetic approaches, transporters, and opioid receptors.

Problems of Drug Dependence 1995: Proceedings of the 57th Annual Scientific Meeting: The College on Problems of Drug Dependence. NIDA Research Monograph 162
548 pp. M162
NIDA Research Monograph 162 contains papers adapted from the symposium meetings and plenary sessions held at the 57th Annual Scientific Meeting and offers the state-of-the-art on many areas encompassing many disciplines in drug abuse research. Abstracts on various research-in-progress are also included, permitting readers to be informed of the latest research developments in the drug abuse field.

Neurotoxicity and Neuropathology Associated with Cocaine Abuse. NIDA Research Monograph 163
(1996) 344 pp. M163
The monograph describes clinical, biochemical, physiological, and psychological aspects of neurotoxicity and neuropathology associated with abuse of cocaine and other psychostimulants. It proposes placing stimulants dependence in the category of neurological disorders in addition to the class of psychiatric disorders. This monograph discusses significance of neuropathologies in phenomology of drug dependence and their relevance in developing successful treatment strategies.

Behavorial Studies of Drug Exposed Offspring: Methodological Issues in Human and Animal Research. NIDA Research Monograph 164
(1996) 300 pp. M164
Although the use of drugs during pregnancy has been a major public health issue in recent years, the scientific literature has been less clear partly because of complex methodological issues that confront research in this field. In July 1993 NIDA conducted a technical review from which this monograph stems. The aim of the technical review and thus the monograph is to clarify the methodological issues for future research in this field, to provide caution in the interpretation of research findings, and to suggest future research directions.

Beyond the Therapeutic Alliance: Keeping the Drug-Dependent Individual in Treatment. NIDA Research Monograph 165
This item is currently out of stock.
(1997, NIDA) 255 pp. M165
Beyond the Therapeutic Alliance reviews current treatment research on the best ways to retain patients in drug dependence treatment, and to guide clinicians and clinical researchers on how to deal with this issue. The monograph addresses the issue of keeping addicted individuals in treatment long enough for the treatment to have a positive effect.

Treatment for Drug-Exposed Women and Their Children: Advances in Research Methodology. NIDA Research Monograph 166
(1996) 322 pp. M166
This monograph presents a sample of what has been learned from the NIDA-funded Perinatal-20 Treatment Research Demonstration Program about: 1) services research implementation; 2) subject selection, recruitment, and retention; 3) clinical assessment and program evaluation; and 4) data management and statistical analyses. Experiences, products, and procedures used in one or more of the Perinatal-20 studies are described.

Rural Substance Abuse: State of Knowledge and Issues. NIDA Research Monograph 168
 (1997, NIDA) 544 pp. M168
Rural Substance Abuse provides significant information about the special nature or context of rural communities, particularly relative to urban settings, that might impact patterns of alcohol and drug consumption and the delivery of services to prevent and treat alcohol and drug abuse.

Laboratory Behavioral Studies of Vulnerability to Drug Abuse. NIDA Research Monograph 169
(1998) 255 pp. M169
This monograph provides comprehensive information on methodological and paradigmatic issues, as well as recommendations for future research directions in the field of behavioral laboratory research on vulnerability to drug abuse.

Meta-Analysis of Drug Prevention Programs. NIDA Research Monograph 170
264 pp. M170
Designed for the drug abuse prevention research and practitioner community, this monograph provides information on recent advances in research integration methods and scientific findings in the area of drug abuse prevention programs.

Treatment of Drug-Dependent Individual with Comorbid Mental Disorders. NIDA Research Monograph 172
170pp. M172
This monograph promotes the effective treatment of individuals with comorbid mental and addictive disorders by reporting state-of-the science treatment research on individuals with comorbid mental and addictive disorders, and research on HIV-related issues in this population.

Pharmacokinetics, Metabolism and Pharmaceutics of Drug Abuse NIDA Research Monograph 173
(1997, NIDA) 316 pp.M173
Volume 173 in this series provides the current status of research on metabolism, pharmacokinetics and pharmacodynamics of drugs of abuse. The report also addresses the ability of the drugs to effectively cross the various membrane barriers and to reach receptors depending upon the nature of the drug moiety.

Problems of Drug Dependence 1996: Proceedings of the 58th Annual Scientific Meeting, the College on Problems of Drug Dependence, Inc. NIDA Research Monograph 174
(1997, NIDA) 462 pp. M174
NIDA Research Monograph 174 provides proceedings from the 1996 meeting of the College on Problems of Drug Dependence. Written by meeting participants, the monograph explores a variety of topics: inhalants, nicotine, marijuana, cocaine, drug abuse and gender differences, drug abuse and adolescents, and drug abuse and pregnant women.

Medication Development for the Treatment of Cocaine Dependence: Issues in Clinical Efficacy Trials. NIDA Research Monograph 175
(1997, NIDA) 329 pp. M175
Designed for use by clinical investigators, pharmaceutical scientists, and treatment researchers, this monograph evaluates the safety and efficacy of potential treatment medications for cocaine addiction.

Cost-Benefit/Cost-Effectiveness Research of Drug Abuse Prevention: Implications for Programming and Policy. NIDA Research Monograph 176
(1998) 233 pp. M176
This monograph provides definitions of prevention program types; informs policymakers, legislators, and program managers about effective prevention program strategies; and disseminates to the scientific research community a synoptic overview of the state-of-the-art of drug abuse prevention as reflected by a critical review of extant drug abuse prevention research.

Drug Abuse Prevention Through Family Interventions. NIDA Research Monograph 177
(1998) 523 pp. M177
NIDA Research Monograph 177 examines ways in which family interventions may prevent drug abuse. Chapters include discussions on family etiology of youth problems, prevention of early adolescent substance abuse among high-risk youth, and selecting parenting measures for assessing family-based prevention interventions.

Problems of Drug Dependence 1997: Proceedings of the 59th Annual Scientific Meeting of the College on Problems of Drug Dependence, Inc. NIDA Research Monograph 178
(1998) 466 pp. M178
Problems of Drug Dependence 1997 is a yearbook of progress in drug abuse research that presents an overview of the drug abuse research field as a whole. Readers will use this publication as a summary of research progress to keep abreast of the latest developments in preclinical, clinical, social, psychological, and psychiatric aspects of drug abuse research.

Problems of Drug Dependence 1998: Proceedings of the 60th Annual Scientific Meeting of the College on Problems of Drug Dependence, Inc. NIDA Research Monograph 179
(1999) 435 pp. M179
This monograph is a comprehensive gathering of scientific information on all aspects of substance abuse. Chapters in the book discuss behavior change in cocaine abusers, adolescent drug abuse, tobacco use, methamphetamine, and many other issues.

Problems of Drug Dependence 1999: Proceedings of the 61st Annual Scientific Meeting, The College on Problems of Drug Dependence
(NIDA, 2000) 476 pp. M180
NIDA Research Monograph 180 provides abstracts of the several hundred research papers which were presented at the 61st Annual Scientific Meeting on Problems of Drug Dependence.

Back to Top

NIDA Research Report Series

NIDA Research Report Series: Cocaine Abuse and Addiction
 (1999) 8 pp. PHD813
Although cocaine is one of the oldest known drugs, it has been labeled the drug of the 1980's and 1990's because of its extensive popularity and use during this period. This report examines the history of cocaine, identifies crack cocaine, and explains the effects and medical complications of cocaine use and abuse. The report also investigates the various treatments for cocaine abuse.

NIDA Research Report Series: Heroin Abuse and Addiction
(1997) 8 pp. PHD742
Heroin use is on the rise, particularly among youth. This report provides information on the prevalence of heroin abuse, methods of use, short- and long-term effects of abuse, and medical complications of chronic abuse. It also describes effective treatment for heroin addiction and lists resources for additional information.

NIDA Research Report Series: Inhalant Abuse: Its Dangers Are Nothing to Sniff at
(1994) 8 pp. PHD675
Based upon recent research on the use and prevalence of inhalants, this research report presents information on the types of inhalants, the consequences of use, who is using inhalants, and where to get help.

NIDA Research Report Series: Methamphetamine Abuse and Addiction
(1998) 8 pp. PHD756
Methamphetamine abuse is a growing problem among a diverse population in urban and rural areas of the United States. This report provides scientific information on methamphetamine abuse, including current epidemiological data regarding its abuse, the short- and long-term effects of abuse, effective treatment methods, and an emphasis on how methamphetamine affects the brain.

NIDA Research Report Series: Nicotine Addiction
(1998) 8 pp. PHD762
This report defines nicotine and describes current epidemiological research data regarding its use; the medical consequences of nicotine use, with an emphasis on the effects of nicotine on the brain; current research findings about use during pregnancy; and treatment approaches.

Back to Top

CSAT Technical Assistance Publications Series

Approaches in the Treatment of Adolescents with Emotional and Substance Abuse Problems. Technical Assistance Publications Series 1
(Reprint 1993) 30 pp. PHD580
Volume 1 in this series addresses the needs of adolescents with substance abuse problems and makes practical recommendations on the implementation of effective treatment methods.

Need, Demand, and Problem Assessment for Substance Abuse Services. Technical Assistance Publications Series 3
(Reprint 1993) 33 pp. PHD582
This report documents more than a dozen methodologies designed to assist in developing more structured approaches to assessing the need for substance abuse treatment services and estimating the demand for services.

Coordination of Alcohol, Drug Abuse, and Mental Health (ADM) Services. Technical Assistance Publications Series 4
(1993) 32 pp. PHD583X
The photocopied version of this TAP describes the major models and mechanisms available and makes recommendations regarding the process of developing coordination among ADM services.

Self-Run, Self-Supported Houses for More Effective Recovery from Alcohol and Drug Addiction. Technical Assistance Publications Series 5
(1993) 130 pp. PHD584X
This photocopy of Self-Run, Self-Supported describes the experience of Oxford House and the mechanics of renting houses to be used as self-run, self-supported recovery houses.

Empowering Families, Helping Adolescents: Family-Centered Treatment of Adolescents with Alcohol, Drug Abuse, and Mental Health Problems. Technical Assistance Publications Series 6
This item is currently out of stock
(Reprint 1994) 204 pp. BKD81
This report describes issues, treatment models, and steps necessary to implement a family-centered approach to adolescent treatment.

Treatment of Opiate Addiction With Methadone: A Counselor's Manual. Technical Assistance Publications Series 7
(CSAT, 1994) 183 pp. BKD151
A manual is presented to facilitate the training of new counselors and to improve the quality of the counseling component of methadone treatment. One of the most important starting points in developing a professional attitude regarding methadone treatment is understanding that methadone is a medication. A second, equally important fact is that methadone does not cure opiate addiction. Current U.S. Food and Drug Administration regulations require that methadone treatment be delivered within an environment that offers supportive counseling and rehabilitation services. Methadone maintenance is the treatment modality that requires the greatest understanding of the rationale and regulations surrounding its use. The rationale, procedures, regulations, and patient care guidelines for the delivery of methadone maintenance treatment are presented. Methadone detoxification is a process that often provides an entry point into the system of opiate treatment. Counselors in methadone programs need to be able to provide specialized information and counseling approaches to patients who have special problems, such as terminal illness, and special groups of patients, such as women. In addition to individual skills and commitment, the methadone program staff needs to operate as a team.

Relapse Prevention and the Substance-Abusing Criminal Offender. Technical Assistance Publications Series 8
(1993) 30 pp. BKD121
In volume 8 of this series, an overview of chemical addiction and the process of recovery are examined. The report also discusses the process of relapse and the principles and procedures of relapse prevention therapy.

Rural Issues in Alcohol and Other Drug Abuse Treatment. Technical Assistance Publications Series 10
(1994) 68 pp. PHD662
Rural Issues presents the papers submitted in the "Award for Excellence" competition co-sponsored by the Center for Substance Abuse Treatment and the National Rural Institute on Alcohol and Drug Abuse. Rural areas face special difficulties in providing high-quality treatment and prevention services to their widely dispersed populations. These papers address various issues and populations specific to rural settings.

Treatment for Alcochol and Other Drug Use: Opportunities for Coordination. Technical Assistance Publications Series 11
(1994) 182 pp. PHD663
The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE.
This publication contains an exhaustive review of the need for and benefit of systemic coordination among State, legislative, public health, criminal justice, and social service entities in order to provide a continuum of comprehensive treatment services.

Approval and Monitoring of Narcotic Treatment Programs: A Guide on the Roles of Federal and State Agencies. Technical Assistance Publications Series 12
(Reprint 1996) 179pp. PHD666
This guide offers a step-by-step description of Federal and State agency rules in approving and monitoring narcotic addiction treatment programs. Contents of this TAP include a history of Federal and State involvement in narcotic treatment and an overview of the approval and monitoring process.

Confidentiality of Patient Records for Alcohol and Other Drug Treatment. Technical Assistance Publications Series 13
(1994) 36 pp. BKD156
The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE.
This guide provides an overview of Federal alcohol and other drug treatment confidentiality law and regulations as well as options for resolving apparent conflicts between Federal comfidentiality requirements and State communicable disease reporting requirements. An appendix presents sample forms for patient consent and qualified service organization agreements.

Siting Drug and Alcohol Treatment Programs: Legal Challenges to the NIMBY Syndrome. Technical Assistance Publication
Series 14
The printed version of this publication is currently out of stock, however, it can still be viewed and printed on PREVline.
(1995) 48 pp. BKD175X
This photocopied TAP covers zoning and other requirements that affect siting, legal challenges to siting barriers, applying legal principles, and how to build a case.

Forecasting the Cost of Chemical Dependency Treatment Under Managed Care: The Washington State Study. Technical Assistance Publication Series 15
(1995) 84 pp. BKD176
Designed for State alcohol and drug agencies, this TAP provides background information and advice in using actuarial studies to predict the costs of contracting with managed care organizations. Washington State's experience in conducting an actuarial estimate of the cost of chemical dependency treatment is provided as an example.

Purchasing Managed Care Services for Alcohol and Other Drug Treatment: Essential Elements and Policy Issues. Technical Assistance Publication Series 16
(1995) 58 pp. BKD167
This TAP provides an overview of managed care, current managed care/medicaid initiatives, and a managed care needs assessment. The report also discusses access, financial considerations, and consumer protections as they relate to treatment.

Treating Alcohol and Other Drug Abusers in Rural and Frontier Areas: 1994 Award for Excellence Papers. Technical Assistance Publications 17
(1995) BKD174
Volume 17 of the TAP series is a compilation of papers submitted in the second nationwide Award for Excellence contest, sponsored jointly by the Center for Substance Abuse Treatment and the National Rural Institute on Alcohol and Drug Abuse. The 18 papers were submitted from a number of different regions of rural and frontier America.

Checklist for Monitoring Alcohol and Other Drug Confidentiality Compliance. Technical Assistance Publications Series 18
(1996) 52 pp. PHD722X
This photocopied TAP serves as a reference for the substance abuse treatment provider on how to resolve issues of maintaining and protecting the confidentiality of patients and their records while they are seeking or receiving treatment for substance abuse.

Counselor's Manual for Relapse Prevention With Chemically Dependent Criminal Offenders. Technical Assistance Publications Series 19
(1996) 182 pp. PHD723
This publication focuses on chemical dependency and the criminal offender and is designed for the paraprofessional counselor. Basic counseling information is explained in simple terms. It is also designed to help the counselor work with people who are using the Appendix-Relapse Prevention Workbook for Chemically Dependent Criminal Offenders. It is based on information that has had better than average results in treating chemically dependent criminal offenders.

Bringing Excellence to Substance Abuse Services in Rural and Frontier America: 1996 Award for Excellence Papers. Technical Assistance Publications Series 20
(1997) 137 pp. BKD220
These papers are a culmination of the third Call for Papers from the Center for Substance Abuse Treatment and the National Rural Institute on Alcohol and Drug Abuse. The papers offer a compelling look at a number of ways in which rural and frontier America is addressing alcohol and drug abuse and the problems that accompany the abuse.

Addiction Counseling Competencies: The Knowledge, Skills, and Attitudes of Professional Practice. Technical Assistance Publications Series 21
(1998) 132 pp. BKD246X
Addiction counselors form relationships with their clients and help them move from addiction to recovery. This TAP focuses on the work of counselors who deal with psychoactive substance use, abuse, and dependence among their clients. Chapters discuss the clinical evaluation, treatment planning, referral, and counseling.

Contracting for Managed Substance Abuse and Mental Health Services: A Guide for Public Purchasers. Technical Assistance Publications Series 22
(1998) 295 pp. BKD252
This TAP presents a comprehensive guide for public purchasers and others interested in influencing the development of requests for proposals (RFPs) and contracts in managed behavioral health care. The guide encourages programmatic success with chapters that cover designing, procuring, and implementing managed care systems, quality management, and consumer protections.

Substance Abuse Treatment for Women Offenders: Guide to Promising Practices. Technical Assistance Publication Series 23 (NOTE: Requires Adobe Acrobat Reader)
(1999) 174 pp. BKD310
This report offers guidelines and ideas for designing promising programs to help addicted women in the criminal justice system. The guide is specifically for State and community-level policymakers who plan and fund substance abuse and corrections programs.

Welfare Reform and Substance Abuse Treatment Confidentiality: General Guidance for Reconciling Need to Know and Privacy. Technical Assistance Publication Series 24
(1999) 40 pp. BKD336
This report provides guidance in resolving issues, faced by alcohol and drug agencies, substance abuse treatment providers, and welfare officials, related to the confidentiality of patient/client information.

Back to Top

CSAT Treatment Improvement Protocol (TIP) Series

Pregnant, Substance-Using Women. Treatment Improvement Protocol (TIP) Series 2
(Reprint 1995) 90 pp. BKD107
Volume 2 of this TIP defines guidelines that reflect state-of-the-art scientific and clinical knowledge on effective treatment practices and care for pregnant addicts.

Screening and Assessment of Alcohol and Other Drug-Abusing Adolescents. Treatment Improvement Protocol (TIP) Series 3
(Reprint 1995) 270 pp. BKD108
For use by practitioners, this TIP offers guidelines for screening and assessing substance-abusing adolescents and ensuring treatment and other social services.

Guidelines for the Treatment of Alcohol and Other Drug-Abusing Adolescents. Treatment Improvement Protocol (TIP) Series 4
(1993) 188 pp. BKD109
This TIP defines guidelines that reflect state-of-the-art scientific and clinical knowledge to be used by practitioners for treatment of substance-abusing adolescents.

Improving Treatment for Drug-Exposed Infants. Treatment Improvement Protocol (TIP) Series 5
(Reprint 1995) 94 pp. BKD110
Guidelines and standards of care in monitoring and evaluating programs treating drug-exposed infants are examined in volume 5 of this series.

Screening for Infectious Diseases Among Substance Abusers. Treatment Improvement Protocol (TIP) Series 6
(Reprint 1995) 160 pp. BKD131
This TIP defines guidelines in establishing funding, monitoring, and evaluating treatment programs that screen for infectious diseases in substance abusers.

Screening and Assessment for Alcohol and Other Drug Abuse Among Adults in the Criminal Justice System. Treatment Improvement Protocol (TIP) Series 7
(1994) 129 pp. BKD138X
This TIP provides guidelines to criminal justice and substance abuse treatment personnel on effective procedures and instruments to ensure appropriate program referral, treatment, and enhanced outcomes.

Intensive Outpatient Treatment for Alcohol and Other Drug Abuse. Treatment Improvement Protocol (TIP) Series 8
(1994) 114 pp. BKD139X
This TIP provides an introductory review of intensive outpatient treatment (IOT), documenting the clinical viability and utility of IOT and stressing the range of IOT services within the broader continuum of care.

Assessment and Treatment of Patients with Coexisting Mental Illness and Alcohol and Other Drug Abuse. Treatment Improvement Protocol (TIP) Series 9
(Reprint 1995) 114 pp. BKD134
Volume 9 of the TIP series provides treatment recommendations that are practical and useful for enhancing services to individuals dually diagnosed with mental health and substance abuse problems.

Assessment and Treatment of Cocaine-Abusing, Methadone-Maintained Patients. Treatment Improvement Protocol (TIP) Series 10
(1994) 129 pp. BKD157
This TIP addresses the treatment needs of methadone patients using opioids and stimulants, especially cocaine and crack-cocaine.

Simple Screening Instruments for Outreach for Alcohol and Other Drug Abuse and Infectious Diseases. Treatment Improvement Protocol (TIP) Series 11
(1994) 82 pp. BKD143X
This TIP presents information on two screening instruments, one for substance abuse and one for infectious diseases, their development, and guidelines for their use. The instruments are designed for linking substance abuse treatment with individuals suffering from HIV/AIDS, TB, and STDs.

Combining Substance Abuse Treatment with Intermediate Sanctions for Adults in the Criminal Justice System. Treatment Improvement Protocol (TIP) Series 12
(1994) 110 pp. BKD144X
This photocopied TIP provides the substance abuse treatment and criminal justice systems with information to enhance the linkage of treatment services for offenders assigned to intermediate sanctions. Planning, policy, ethical, and legal issues are discussed.

The Role and Current Status of Patient Placement Criteria in the Treatment of Substance Use Disorders. Treatment Improvement Protocol (TIP) Series 13
(1995) 84 pp. BKD161
An objective of the substance abuse treatment field is to establish standardized patient placement criteria (PPC). This TIP will help readers understand what PPC are learned from the experiences of others who have helped develop currently used criteria. It also lays the groundwork for a concerted effort to develop national uniform patient placement criteria.

Developing State Outcomes Monitoring Systems for Alcohol and Other Drug Abuse Treatment. Treatment Improvement Protocol (TIP) Series 14
(1995) BKD162
Volume 14 of this series is designed to help single State agencies and their staff develop, implement, and manage outcomes monitoring systems (OMSs) for local substance abuse treatment programs to increase accountability for treatment expenditures. This TIP will be of interest to anyone who wants to improve patient matching and treatment.

Treatment for HIV-Infected Alcohol and Other Drug Abusers. Treatment Improvement Protocol (TIP) Series 15
(1995) BKD163
All HIV-infected substance abusers, regardless of the setting in which they receive care, should have available to them a spectrum of core services and treatment approaches. This TIP identifies these necessary core services and approaches. It also provides recommendations and guidelines for quality care for substance abusers in treatment who are infected with HIV.

Alcohol and Other Drug Screening of Hospitalized Trauma Patients. Treatment Improvement Protocol (TIP) Series 16
(1995) BKD164
Alcohol and drugs frequently play a significant role in traumatic injury, especially re-injury. The TIP recommends alcohol and drug screening (blood and urine) of injured patients, ages 14 and older, at hospital admission. A comprehensive substance abuse assessment is outlined, and some brief intervention techniques are described.

Planning for Alcohol and Other Drug Abuse Treatment for Adults in the Criminal Justice System. Treatment Improvement Protocol Series 17
(1995) 116 pp. BKD165
Chapters in volume 17 discuss the effectiveness of substance abuse treatment in the criminal justice system; the offenders and their related issues, such as HIV/AIDS, mental disorders, sexual abuse, and violence; and the substance abuse treatment system overall. The TIP describes how coordination, collaboration, and training can take place and how confidentiality should be handled.

The Tuberculosis Epidemic: Legal and Ethical Issues for Alcohol and Other Drug Abuse Treatment Providers. Treatment Improvement Protocol Series 18
(1995) 132 pp. BKD173
This TIP describes the tuberculosis disease and modes of transmission, how substance abuse programs can play their part in preventing or treating TB patients, and how TB can be prevented in the workplace. Related issues such as discrimination and confidentiality are discussed.

Detoxification From Alcohol and Other Drugs. Treatment Improvement Protocol Series 19
(1995) 94 pp. BKD172
This TIP covers detoxification settings and patient matching, clinical detoxification protocols, improving quality and measuring outcomes, and costs and current payment mechanisms for detoxification services. Special populations such as women, elderly persons, patients who are HIV positive, and incarcerated persons are also discussed.

Matching Treatment to Patient Needs in Opioid Substitution Therapy. Treatment Improvement Protocol (TIP) Series 20
(1995) BKD168
Persons with addictions to opioids often need a broad range of services in addition to opioid substitution therapy. Research has shown that providing these services as part of the therapy program greatly increases retention in treatment and improves outcomes. This TIP offers guidelines to providers who deliver quality treatment to opiate-addicted persons.

Combining Alcohol and Other Drug Abuse Treatment with Diversion for Juveniles in the Justice System. Treatment Improvement Protocol (TIP) Series 21
(1995) 130 pp. BKD169
This TIP covers the goals of substance abuse treatment-focused diversion program goals, diversion program collaborating, and juvenile diversion to substance abuse treatment planning.

LAAM in the Treatment of Opiate Addiction. Treatment Improvement Protocol (TIP) Series 22
(1995) BKD170
Levo-alpha-acetyl-methadol (LAAM) is an opioid agonist medication approved for use by the Food and Drug Administration in 1993. This TIP describes the medication itself, its modes of action, possible side effects, and interactions with other medications. Separate chapters describe treatment planning, program administration, and regulatory and ethical issues.

Treatment Drug Courts: Integrating Substance Abuse Treatment With Legal Case Processing. Treatment Improvement Protocol (TIP) Series 23
(1996) 66 pp. BKD205
Volume 23 of this TIP will help policymakers and practitioners plan, implement, monitor, and evaluate programs that effectively integrate substance abuse treatment in the pretrial processing of criminal cases. TIP 23 was developed to encourage agencies creating and participating in these programs to share information about their sucesses and failures so that substance abuse treatment will be effectively integrated into pretrial case processing.

A Guide to Substance Abuse Services for Primary Care Clinicians. Treatment Improvement Protocol (TIP) Series 24
(1997) 168 pp. BKD234
This document gives primary care clinicians specific guidance on identifying indications of substance abuse, how to broach the subject with a patient, and what screening and assessment instruments to use. It explains how to perform an office-based brief intervention in which patient and clinician set mutually agreed upon goals and "contract" to stop or cut back the alcohol or other drug use. The TIP also discusses the elements of in-depth assessments, appropriate referrals, and specialized treatment.

Other Publications Related to TIP 24:

Substance Abuse Treatment and Domestic Violence. Treatment Improvement Protocol (TIP) Series 25
(1997, CSAT) 152 pp. BKD239
Designed for treatment providers, this TIP presents an introduction to the field of domestic violence. It offers providers useful information on the role of substance abuse in domestic violence—both among the men who batter and the women who are battered. Useful techniques for detecting and eliciting such information are supplied, along with ways to modify treatment to ensure victims' safety and to stop the cycle of violence in both parties' lives. Legal issues are discussed and the TIP provides a blueprint for a more integrated system of care that would enhance treatment for both problems.

Substance Abuse Among Older Adults. Treatment Improvement Protocol (TIP) Series 26
(1998) 173 pp. BKD250
Adults ages 60 and older tend to be overlooked in discussions of substance abuse, resulting in thousands of older adults who need treatment and do not receive it. This TIP recommends practices for identifying, screening and assessing, and treating alcohol and prescription drug abuse among older adults. TIP 26 is designed for substance abuse treatment providers, primary care clinicians, social workers, and senior center staff.

Comprehensive Case Management for Substance Abuse Treatment. Treatment Improvement Protocol (TIP) Series 27
(1998) 121 pp. BKD251
A history of case management, including models of case management with substance abusers, is provided in this TIP. The TIP also covers case management for clients with special needs, funding case management in managed care environments, and application of case management to substance abuse treatment.

Naltrexone and Alcoholism Treatment. Treatment Improvement Protocol (TIP) Series 28
(1998) 94 pp. BKD268
Naltrexone therapy, in combination with psychosocial programs, can improve alcoholism treatment outcomes. In many patients, naltrexone reduces the urge to drink, giving the patient the opportunity to learn to stay sober without it. This TIP will help clinicians and treatment providers use naltrexone safely and effectively to enhance patient care and improve treatment outcomes.

Substance Use Disorder Treatment for People with Physical and Cognitive Disabilities. Treatment Improvement Protocol (TIP) Series 29
(1998) 156 pp. BKD288
People with physical and cognitive disabilities are more likely to have a substance use disorder and less likely to get effective treatment for it than those without such a coexisting disability. This TIP explains the issues in treating people with coexisting disabilities, discusses how to screen for coexisting disorders and how to adapt substance use screening for clients who have a disability, and examines treatment planning and counseling.

Screening and Assessing Adolescents for Substance Use Disorders. Treatment Improvement Protocol (TIP) Series 31
(1999) 136 pp. BKD306
Substance use can disrupt a young person's ability to meet developmental tasks and impair identity development, a central theme of adolescence. This TIP presents information on identifying, screening, and assessing substance use in adolescents. Since adolescents differ from adults physiologically and emotionally, it is important for professionals who come into regular contact with youth to recognize the signs of substance use. The TIP focuses on the most current procedures and instruments for detecting substance abuse among adolescents, conducting comprehensive assessments, and beginning treatment planning.

Treatment of Adolescents with Substance Use Disorders. Treatment Improvement Protocol (TIP) Series 32
(1999) 126 pp. BKD307
This TIP presents information on substance use disorder treatment for adolescent clients. Adolescents differ from adults physiologically and emotionally as they make the transition from child to adult and require treatment adapted to their needs. In order to treat this population effectively, treatment providers must address the issues that play significant roles in an adolescent's life, such as cognitive, emotional, physical, social, and moral development, and family and peer environment. The TIP focuses on ways to specialize treatment for adolescents, as well as on common and effective program components and approaches being used today.

Treatment for Stimulant Use Disorders. Treatment Improvement Protocol (TIP) Series 33
(1999) 226 pp. BKD289
Stimulant use has risen dramatically in the United States over the last 20 years. This TIP explains the nature and treatment of stimulant use disorders. The TIP also reviews what is currently known about treating the medical, psychiatric, and substance abuse/dependence problems associated with cocaine and methamphetamine use.

Enhancing Motivation for Change in Substance Abuse Treatment. Treatment Improvement Protocol (TIP) Series 35
(1999, CSAT) 243 pp. BKD342
This TIP shows how substance abuse treatment staff can influence change by developing a therapeutic relationship that respects and builds on the client's autonomy and, at the same time, makes the treatment clinician a partner in the change process.

Substance Abuse Treatment Responding to Child Abuse and Neglect Issues: Treatment Improvement Protocol 36
(2000, CSAT) 181 pp. BKD343
The effects of childhood abuse and neglect perpetrated by family members and the intergenerational transmission of the cycle of substance abuse and child abuse and neglect are the focus of this TIP. The seven chapters discuss working with child abuse and neglect issues; screening and assessing adults for childhood abuse and neglect; comprehensive treatment for adult survivors; therapeutic issues for counselors; the substance-dependent client as parent/caregiver; legal responsibilities; and emerging and continuing issues. The closing recommendations include screening assessment protocol and issues for counselors.

Substance Abuse Treatment for Persons with HIV/AIDS: Treatment Improvement Protocol (TIP) Series 37
(CSAT, 2000) 316 pp. BKD359
This installment of the Treatment Improvement Protocol (TIP) Series discusses the unique substance abuse treatment needs of a person with HIV/AIDS. Topics covered include a general overview of HIV/AIDS, medical treatment, mental health treatment, primary and secondary modes of HIV prevention, and many other pertinent issues.
Other items related to TIP 37 include:
Back to Top

SAMHSA Managed Care Technical Assistance Series

An Evaluation of Contracts Between Managed Care Organizations and Community Mental Health and Substance Abuse Treatment and Prevention Agencies. Volume 1
(1997, SAMHSA) 60 pp. BKD240
Volume 1 of this series examines the structure and content of provider network agreements between managed care organizations and community mental health and substance abuse treatment and prevention agencies.

Designing Substance Abuse and Mental Health Capitation Projects: A Managed Care Guide for State and Local Officials. Volume 3
(1998, SAMHSA) 62 pp. BKD290
Public sector substance abuse and mental health agencies are helped through the design of quality capitation projects in this guide. The guide also includes a step-by-step approach to becoming a "smart purchaser" of capitated substance abuse and mental health services. This guide is a reference tool that reviews the options available to capitation designers and the relative merits and drawbacks of the alternatives.

Estimating and Managing Risks for the Utilization and Cost of Mental Health and Substance Abuse Services in a Managed Care Environment. Volume 4
(1998, SAMHSA) 109 pp. BKD291
Estimating and Managing Risks discusses the principles and implementation of risk-sharing provider payment systems used in managed care systems. Sections of the manual discuss such topics as how to measure and manage risk, factors to consider when developing risk estimates, and managing risks after the contract is signed.

Ethical Issues for Behavioral Health Care Practitioners and Organizations in a Managed Care Environment. Volume 5
(1998, SAMHSA) 32 pp. BKD292
This guide explores core ethical issues in managed behavioral health care, including the ethical principles underlying debate regarding the overall allocation of health care resources. Ethical issues confronting the behavioral health care organization in a managed care environment are also discussed.

Legal Issues Associated with Development and Implementation of Provider-Sponsored Managed Care Organization. Volume 6
(1998, SAMHSA) 65 pp. BKD296
Volume 6 in this series summarizes the legal issues that substance abuse service and mental health providers must address when organizing provider-sponsored managed care organizations (MCO's) and when implementing managed care programs through contract negotiation and the delivery of services and care through provider contracts.

Partners in Planning: Consumers' Role in Contracting for Public-Sector Managed Mental Health and Addiction Services. Volume 10
(1998, SAMHSA) 104 pp. BKD293
Consumers and families are guided through the process of identifying and advocating for the best possible managed care contracting practices in Volume 10 of this series. Chapters explore the contracting process, the contract content and services, consumer rights, and quality assurance.

Back to Top



Search PREVLINE Online Catalog PREVLINE Home Questions NCADI Services